DK123655B - Analogifremgangsmåde til fremstilling af pyridoindolderivater eller syreadditionssalte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af pyridoindolderivater eller syreadditionssalte deraf.Info
- Publication number
- DK123655B DK123655B DK249367AA DK249367A DK123655B DK 123655 B DK123655 B DK 123655B DK 249367A A DK249367A A DK 249367AA DK 249367 A DK249367 A DK 249367A DK 123655 B DK123655 B DK 123655B
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- acid addition
- addition salts
- analogous process
- pyridoindole derivatives
- Prior art date
Links
- IVCGJOSPVGENCT-UHFFFAOYSA-N 1h-pyrrolo[2,3-f]quinoline Chemical class N1=CC=CC2=C(NC=C3)C3=CC=C21 IVCGJOSPVGENCT-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54945566A | 1966-05-12 | 1966-05-12 | |
| US628530A US3409628A (en) | 1966-05-12 | 1967-04-05 | 5-(3-pyridylethyl)pyridoindole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK123655B true DK123655B (da) | 1972-07-17 |
Family
ID=27069138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK249367AA DK123655B (da) | 1966-05-12 | 1967-05-11 | Analogifremgangsmåde til fremstilling af pyridoindolderivater eller syreadditionssalte deraf. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3409628A (da) |
| BE (1) | BE698183A (da) |
| CH (1) | CH494234A (da) |
| DE (1) | DE1695187A1 (da) |
| DK (1) | DK123655B (da) |
| ES (1) | ES340412A1 (da) |
| FI (1) | FI48093C (da) |
| FR (2) | FR7024M (da) |
| GB (3) | GB1173999A (da) |
| IL (1) | IL27956A (da) |
| NL (1) | NL6706671A (da) |
| NO (1) | NO123950B (da) |
| SE (1) | SE342231B (da) |
| YU (1) | YU94367A (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4696930A (en) * | 1985-04-12 | 1987-09-29 | Hoffmann-La Roche Inc. | N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents |
| RU2339637C1 (ru) * | 2007-04-05 | 2008-11-27 | Андрей Александрович Иващенко | Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием |
| AU2008302751A1 (en) * | 2007-09-20 | 2009-03-26 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
| EP2236511A4 (en) * | 2007-12-21 | 2011-04-13 | Alla Chem Llc | LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF |
| US9625475B2 (en) * | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
| TW201018694A (en) * | 2008-09-29 | 2010-05-16 | Abbott Lab | Indole and indoline derivatives and methods of use thereof |
| US8703952B2 (en) | 2008-12-12 | 2014-04-22 | Wista Laboratories Ltd. | Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline and analogues and intermediates |
| CA2748813C (en) | 2009-01-09 | 2018-07-10 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9162980B2 (en) | 2009-01-09 | 2015-10-20 | Board Of Regents Of The University Of Texas System | Anti-depression compounds |
| US8362277B2 (en) * | 2009-01-09 | 2013-01-29 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9095572B2 (en) | 2009-01-09 | 2015-08-04 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9962368B2 (en) | 2009-01-09 | 2018-05-08 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| WO2010127177A1 (en) | 2009-04-29 | 2010-11-04 | Medivation Technologies, Inc. | Pyrido [4,3-b] indoles and methods of use |
| WO2011019417A1 (en) | 2009-04-29 | 2011-02-17 | Medivation Technologies, Inc. | Pyrido [4, 3-b] indoles and methods of use |
| WO2011008312A2 (en) | 2009-07-14 | 2011-01-20 | Abbott Laboratories | Indole and indoline derivatives and methods of use thereof |
| CA2829045A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
| EP2887803A4 (en) | 2012-08-24 | 2016-08-03 | Univ Texas | PRO-NEUROGENIC COMPOUNDS |
| WO2015070237A1 (en) | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Neuroprotective chemicals and methods for identifying and using same |
| EP3068388A4 (en) | 2013-11-11 | 2017-04-12 | Board of Regents of the University of Texas System | Neuroprotective compounds and use thereof |
| US12084440B2 (en) * | 2021-02-01 | 2024-09-10 | Bigespas Ltd. | Polymorph of latrepirdine dihydrochloride |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2786059A (en) * | 1951-04-30 | 1957-03-19 | Schenley Ind Inc | Derivatives of 2-nu-methyl-1, 2, 3, 4-tetrahydro-gamma-carbolines |
-
1967
- 1967-04-05 US US628530A patent/US3409628A/en not_active Expired - Lifetime
- 1967-05-02 CH CH632467A patent/CH494234A/de not_active IP Right Cessation
- 1967-05-05 DE DE19671695187 patent/DE1695187A1/de active Pending
- 1967-05-09 FR FR105641A patent/FR7024M/fr not_active Expired
- 1967-05-09 BE BE698183D patent/BE698183A/xx unknown
- 1967-05-09 FR FR105640A patent/FR1522686A/fr not_active Expired
- 1967-05-10 IL IL27956A patent/IL27956A/en unknown
- 1967-05-11 GB GB29346/69A patent/GB1173999A/en not_active Expired
- 1967-05-11 ES ES340412A patent/ES340412A1/es not_active Expired
- 1967-05-11 DK DK249367AA patent/DK123655B/da unknown
- 1967-05-11 YU YU00943/67A patent/YU94367A/xx unknown
- 1967-05-11 NO NO168102A patent/NO123950B/no unknown
- 1967-05-11 GB GB29345/69A patent/GB1173998A/en not_active Expired
- 1967-05-11 GB GB21874/67A patent/GB1173997A/en not_active Expired
- 1967-05-12 SE SE6699/67A patent/SE342231B/xx unknown
- 1967-05-12 NL NL6706671A patent/NL6706671A/xx unknown
- 1967-05-12 FI FI671366A patent/FI48093C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| GB1173998A (en) | 1969-12-10 |
| SE342231B (da) | 1972-01-31 |
| FI48093C (fi) | 1974-06-10 |
| GB1173999A (en) | 1969-12-10 |
| NO123950B (da) | 1972-02-07 |
| FI48093B (da) | 1974-02-28 |
| CH494234A (de) | 1970-07-31 |
| IL27956A (en) | 1972-06-28 |
| NL6706671A (da) | 1967-11-13 |
| FR1522686A (fr) | 1968-04-26 |
| US3409628A (en) | 1968-11-05 |
| DE1695187A1 (de) | 1971-04-08 |
| GB1173997A (en) | 1969-12-10 |
| YU94367A (en) | 1974-08-31 |
| BE698183A (da) | 1967-11-09 |
| ES340412A1 (es) | 1968-06-01 |
| FR7024M (da) | 1969-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK125417B (da) | Analogifremgangsmåde til fremstilling af amino-dihalogenphenylethylaminer eller syreadditionssalte deraf. | |
| DK120750B (da) | Analogifremgangsmåde til fremstilling af azaspiroalkandion-forbindelser eller syreadditionssalte deraf. | |
| DK124824B (da) | Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf. | |
| DK123022B (da) | Analogifremgangsmåde til fremstilling af amino-monohalogen-phenylethanolaminer eller syreadditionssalte deraf. | |
| DK121302B (da) | Fremgangsmåde til fremstilling af imidazolderivater eller syreadditionssalte deraf. | |
| DK120389B (da) | Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf. | |
| DK132411B (da) | Analogifremgangsmåde til fremstilling af pyrrylaminoketonderivater eller syreadditionssalte deraf. | |
| DK118607B (da) | Analogifremgangsmåde til fremstilling af 2-phenylhydrazino-imidazolin-2-forbindelser eller syreadditionssalte deraf. | |
| DK119059B (da) | Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf. | |
| DK129238B (da) | Fremgangsmåde til fremstilling af morphinanderivater eller syreadditionssalte deraf. | |
| DK114482B (da) | Analogifremgangsmåde til fremstilling af 7-(picolylaminoalkyl)-theophylliner eller syreadditionssalte deraf. | |
| DK115849B (da) | Fremgangsmåde til fremstilling af substituerede 2-anilinomethyl-imidazoliner eller syreaddtitionssalte heraf. | |
| DK129924B (da) | Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf. | |
| DK121367B (da) | Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf. | |
| DK120640B (da) | Analogifremgangsmåde til fremstilling af aminoalkyl-substituerede phthalaner eller syreadditionssalte deraf. | |
| DK126327B (da) | Analogifremgangsmåde til fremstilling af derivater af p-aminoalkylbenzensulfonamid eller syreadditionssalte deraf. | |
| DK127066B (da) | Analogifremgangsmåde til fremstilling af 5-[phenyldehydropiperidinyl-eller phenyldehydropyrrolidinyl-ethyl]-2-oxazolidinoner eller syreadditionssalte deraf. | |
| DK134159B (da) | Analogifremgangsmåde til fremstilling af nitrofurylquinolinderivater eller nitrogenoxider eller syreadditionssalte deraf. | |
| DK117636B (da) | Fremgangsmåde til fremstilling af diazocin- eller diazecinderivater eller syreadditionssalte deraf. | |
| DK116662B (da) | Fremgangsmåde til fremstilling af pyrazinamider eller syreadditionssalte deraf. | |
| DK120133B (da) | Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf. | |
| DK130587B (da) | Analogifremgangsmåde til fremstilling af difenylpyridazoner eller syreadditionssalt deraf. | |
| DK111031B (da) | Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf. | |
| DK121375B (da) | Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf. | |
| DK121603B (da) | Analogifremgangsmåde til fremstilling af arylcarbinoler eller syreadditionssalte deraf. |